Voleon Capital Management’s AbbVie ABBV Stock Holding History

Voleon Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.5M	Buy	172,753 +8,749	+5%	+$1.88M	0.79%	18
2026 Q1	$35.7M	Buy	164,004 +29,739	+22%	+$6.6M	0.77%	18
2025 Q4	$30.7M	Buy	134,265 +26,707	+25%	+$6.08M	0.66%	21
2025 Q3	$24.9M	Buy	107,558 +58,681	+120%	+$11.9M	0.61%	24
2025 Q2	$9.07M	Sell	48,877 -12,157	-20%	-$2.26M	0.5%	40
2025 Q1	$12.8M	Sell	61,034 -3,011	-5%	-$585K	1%	17
2024 Q4	$11.4M	Buy	+64,045	New	+$11.8M	0.85%	16
2019 Q3	–	Sell	-177,000	Closed	-$12.9M	–	149
2019 Q2	$12.9M	Buy	+177,000	New	+$13.9M	0.74%	35

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Voleon Capital Management's ABBV Position: Q2 2026 in Review

Voleon Capital Management increased its AbbVie (ABBV) stake by 5.3% in Q2 2026, buying an estimated $1.88M and bringing the position to 172,753 shares worth $43.5M. The position accounts for 0.79% of the portfolio, ranked #18.

Voleon Capital Management first reported a position in ABBV in Q2 2019 and has held it in 8 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Voleon Capital Management held 172,753 shares of AbbVie worth $43.5M as of Q2 2026.
Voleon Capital Management bought 8,749 AbbVie shares in Q2 2026, an estimated $1.88M.
AbbVie made up 0.79% of Voleon Capital Management's portfolio in Q2 2026, its #18 holding.
Voleon Capital Management first reported a position in AbbVie in Q2 2019 and has held it in 8 quarters since.
4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.